Development and validation of sampling and rapid assay methods for vedozilumab and ustekinumab therapeutic drug monitoring
Identification and Validation of a Predictive Serological Biomarker Signature for Therapeutic Response to Anti-TNF, Vedolizumab, and Ustekinumab
Improving treatment outcomes for patients with chronic inflammatory diseases through identification of predictive biomarkers and therapeutic drug monitoring of new biologicals
Pharmacometric models for improved therapeutic drug monitoring of ceftriaxone, posaconazole and infliximab
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST)
Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on Ustekinumab
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease
Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study